Spectrogen Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
- Paid Up Capital ₹ 9.62 Cr
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.65 Cr
- Revenue Growth -33.73%
- Profit Growth 518.28%
- Ebitda 392.95%
- Net Worth 293.84%
- Total Assets 48.95%
About Spectrogen Pharmachem
Spectrogen Pharmachem Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 22 December 2020 (Four years and one month 8 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Spectrogen International Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 9.62 Cr.
The company currently has active open charges totaling ₹1.65 Cr.
The Key Managerial Personnel (KMP) at Spectrogen Pharmachem Limited India is Mounika Arshakota as CFO. Srinivasa Marni, Vyasmurti Shingatgeri, Leela Konda, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299TG2020PLC147109
- Company No.
147109
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Spectrogen Pharmachem?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushanam Busi  | Managing Director | 30-Jan-2024 | Current |
| Mounika Arshakota | CFO | 30-Jan-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Marni | Whole-Time Director | 16-Mar-2023 | Current |
| Vyasmurti Shingatgeri | Director | 09-Feb-2024 | Current |
| Leela Konda | Director | Current | |
| Gundluru Reddeppa | Director | 30-Jan-2024 | Current |
Financial Performance of Spectrogen Pharmachem.
Spectrogen Pharmachem Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.73% decrease. The company also saw a substantial improvement in profitability, with a 518.28% increase in profit. The company's net worth Soared by an impressive increase of 293.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectrogen Pharmachem?
Unlock access to Spectrogen Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vanta Bioscience LimitedVyasmurti Shingatgeri is a mutual person
Rs Infrapro Private LimitedSrinivasa Marni is a mutual person
- Luit Infratech Private Limited
Srinivasa Marni is a mutual person
- Winkem Industries Private Limited
Srinivasa Marni is a mutual person
- Techframe Soft Innovations Llp
Leela Konda is a mutual person
- Ramya Sai Analytical Labs Private Limited
Bhushanam Busi is a mutual person
Charges (Loans)
₹1.65 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2021 | Others | ₹1.65 Cr | Open |
How Many Employees Work at Spectrogen Pharmachem?
Spectrogen Pharmachem has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectrogen Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrogen Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
